These findings underscore the diverse biological functions associated with SEPN1 in glioma, encompassing immune-related processes, signaling pathways, and metabolic pathways, which could be pivotal in understanding tumor behavior and developing targeted therapies. This evidence concerns the gene SELENON and neoplasm.